TSXV:RHT.H - Post by User
Comment by
lscfaon Sep 01, 2021 8:22pm
340 Views
Post# 33799052
RE:Jan guidance is dated
RE:Jan guidance is dated Co also needs to provide more guidance on ebitda. They say they will reach 45% margin when they hit 40,000 patients Dec 31 ($24vmil run rate rev). But the margin must climb with more patients. There is no way overhead goes from $10 mil to $36 mil as patient count climbs to 200,000. I suggest they can get to 60% ebitda margin.
p.s. The Jul 28 NR is misleading. The $11 million revenue in calender 2021 will NOT generate 75% gross margin or 45% ebitda margin. Who proof-reads this stuff?
"We remain on track to generate $11 Million in revenue this calendar year, with gross margins of over 75% and EBITDA margins of over 45%. We expect to exit December 2021 at a revenue run rate of $2 Million per month or $24 Million annually."
| Patients | 200,000 | 200,000 |
| Revenue @ $50/month | 120,000,000 | 120,000,000 |
| Gross margin | 75% | 75% |
| Gross profit | 90,000,000 | 90,000,000 |
| Cash Overhead | 18,000,000 | 36,000,000 |
| Op inc (ebitda) | 72,000,000 | 54,000,000 |
| ebitda margin | 60% | 45% |
| Diluted shs | 195,200,548 | 195,200,548 |
| ebitda/sh | $0.369 | $0.277 |
| Multiple | 15 | 15 |
| Sh value | $5.533 | $4.150 |